Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA).

Ciandrini E, Morroni G, Arzeni D, Kamysz W, Neubauer D, Kamysz E, Cirioni O, Brescini L, Baffone W, Campana R.

Curr Top Med Chem. 2018;18(24):2116-2126. doi: 10.2174/1568026618666181022140348.

PMID:
30345920
2.

Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer.

Matassa DS, Amoroso MR, Lu H, Avolio R, Arzeni D, Procaccini C, Faicchia D, Maddalena F, Simeon V, Agliarulo I, Zanini E, Mazzoccoli C, Recchi C, Stronach E, Marone G, Gabra H, Matarese G, Landriscina M, Esposito F.

Cell Death Differ. 2016 Sep 1;23(9):1542-54. doi: 10.1038/cdd.2016.39. Epub 2016 May 20.

3.

TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways.

Agliarulo I, Matassa DS, Amoroso MR, Maddalena F, Sisinni L, Sepe L, Ferrari MC, Arzeni D, Avolio R, Paolella G, Landriscina M, Esposito F.

Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2570-9. doi: 10.1016/j.bbamcr.2015.05.034. Epub 2015 Jun 10.

4.

In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.

Simonetti O, Silvestri C, Arzeni D, Cirioni O, Kamysz W, Conte I, Staffolani S, Orsetti E, Morciano A, Castelli P, Scalise A, Kamysz E, Offidani AM, Giacometti A, Barchiesi F.

Mycoses. 2014 Apr;57(4):233-9. doi: 10.1111/myc.12148. Epub 2013 Oct 16.

PMID:
26058322
5.

Intestinal parasitosis: data analysis 2006-2011 in a teaching hospital of Ancona, Italy.

Silvestri C, Greganti G, Arzeni D, Morciano A, Castelli P, Barchiesi F, Cirioni O, Giacometti A.

Infez Med. 2013 Mar;21(1):34-9.

6.

An atypical, pigment-producing Metschnikowia strain from a leukaemia patient.

Savini V, Hendrickx M, Sisti M, Masciarelli G, Favaro M, Fontana C, Pitzurra L, Arzeni D, Astolfi D, Catavitello C, Polilli E, Farina C, Fazii P, D'Antonio D, Stubbe D.

Med Mycol. 2013 May;51(4):438-43. doi: 10.3109/13693786.2012.733429. Epub 2012 Nov 21.

PMID:
23170963
7.

In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection.

Silvestri C, Cirioni O, Arzeni D, Ghiselli R, Simonetti O, Orlando F, Ganzetti G, Staffolani S, Brescini L, Provinciali M, Offidani A, Guerrieri M, Giacometti A.

Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1759-64. doi: 10.1007/s10096-011-1498-1. Epub 2011 Dec 11.

PMID:
22160846
8.

In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida spp.

Kamysz E, Simonetti O, Cirioni O, Arzeni D, Ganzetti G, Campanati A, Giacometti A, Gabrielli E, Silvestri C, Kamysz W, Offidani A, Barchiesi F.

Peptides. 2011 Jan;32(1):99-103. doi: 10.1016/j.peptides.2010.10.022. Epub 2010 Nov 3.

PMID:
21055432
9.

In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.

Simonetti O, Ganzetti G, Arzeni D, Campanati A, Marconi B, Silvestri C, Cirioni O, Gabrielli E, Lenci I, Kamysz W, Kamysz E, Giacometti A, Scalise G, Barchiesi F, Offidani A.

Peptides. 2009 Oct;30(10):1794-7. doi: 10.1016/j.peptides.2009.06.033. Epub 2009 Jul 8.

PMID:
19591887
10.

In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes.

Simonetti O, Arzeni D, Ganzetti G, Silvestri C, Cirioni O, Gabrielli E, Castelletti S, Kamysz W, Kamysz E, Scalise G, Offidani A, Barchiesi F.

Br J Dermatol. 2009 Aug;161(2):249-52. doi: 10.1111/j.1365-2133.2009.09166.x. Epub 2009 Apr 29.

PMID:
19438437
11.

In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents.

Barchiesi F, Silvestri C, Arzeni D, Ganzetti G, Castelletti S, Simonetti O, Cirioni O, Kamysz W, Kamysz E, Spreghini E, Abruzzetti A, Riva A, Offidani AM, Giacometti A, Scalise G.

Med Mycol. 2009 May;47(3):321-6. doi: 10.1080/13693780802641920. Epub 2008 Dec 27.

PMID:
19115137
12.

In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp.

Barchiesi F, Giacometti A, Cirioni O, Arzeni D, Kamysz W, Silvestri C, Licci A, Marigliano A, Della Vittoria A, Nadolski P, Łukasiak J, Scalise G.

J Chemother. 2007 Oct;19(5):514-8.

PMID:
18073150
13.

In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans.

Barchiesi F, Giacometti A, Cirioni O, Arzeni D, Silvestri C, Kamysz W, Abbruzzetti A, Riva A, Kamysz E, Scalise G.

Peptides. 2007 Aug;28(8):1509-13. Epub 2007 Jul 17.

PMID:
17698253
14.

Fluconazole susceptibility of Candida spp. isolates collected over nine years in a teaching hospital of Ancona, Italy.

Barchiesi F, Arzeni D, Greganti G, Marigliano A, Tomassetti S, Spreghini E, Scalise G.

J Chemother. 2007 Feb;19(1):58-61.

PMID:
17309852
15.

Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.

Barchiesi F, Spreghini E, Tomassetti S, Della Vittoria A, Arzeni D, Manso E, Scalise G.

Antimicrob Agents Chemother. 2006 Aug;50(8):2719-27.

16.

Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.

Barchiesi F, Spreghini E, Tomassetti S, Arzeni D, Giannini D, Scalise G.

Antimicrob Agents Chemother. 2005 Dec;49(12):4989-92.

17.

Caspofungin in combination with amphotericin B against Candida glabrata.

Barchiesi F, Spreghini E, Fothergill AW, Arzeni D, Greganti G, Giannini D, Rinaldi MG, Scalise G.

Antimicrob Agents Chemother. 2005 Jun;49(6):2546-9.

18.

Epidemiology of onychomycosis and paronychia in the area of ANCONA (ITALY) over a period of 5 years.

Simonetti O, Bernardini ML, Arzeni D, Cellini A, Barchiesi F, Offidani A.

Mycopathologia. 2004 Oct;158(3):271-4.

PMID:
15645167
19.

Sequential therapy with caspofungin and fluconazole for Candida albicans infection.

Barchiesi F, Spreghini E, Baldassarri I, Marigliano A, Arzeni D, Giannini D, Scalise G.

Antimicrob Agents Chemother. 2004 Oct;48(10):4056-8.

20.

Antifungal susceptibility patterns of yeast isolates causing bloodstream infections.

Barchiesi F, Caggiano G, Maracci M, Arzeni D, Scalise G, Montagna MT.

J Antimicrob Chemother. 2003 Feb;51(2):431-3.

PMID:
12562717
21.

In vitro and in vivo anticryptococcal activities of a new pyrazolo-isothiazole derivative.

Barchiesi F, Milici ME, Arzeni D, Schimizzi AM, Pizzo G, Giammanco GM, Giannini D, Manfrini M, Scalise G, Vicentini CB.

J Antimicrob Chemother. 2003 Jan;51(1):167-70.

PMID:
12493804
22.

Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy.

Barchiesi F, Maracci M, Radi B, Arzeni D, Baldassarri I, Giacometti A, Scalise G.

J Antimicrob Chemother. 2002 Dec;50(6):999-1002.

PMID:
12461023
23.

Genotyping and antifungal susceptibility of human subgingival Candida albicans isolates.

Pizzo G, Barchiesi F, Falconi Di Francesco L, Giuliana G, Arzeni D, Milici ME, D'Angelo M, Scalise G.

Arch Oral Biol. 2002 Mar;47(3):189-96.

PMID:
11839354
24.

In vitro activity of posaconazole against clinical isolates of dermatophytes.

Barchiesi F, Arzeni D, Camiletti V, Simonetti O, Cellini A, Offidani AM, Scalise G.

J Clin Microbiol. 2001 Nov;39(11):4208-9.

25.

Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections.

Barchiesi F, Di Francesco LF, Arzeni D, Caselli F, Simonetti O, Cellini A, Giacometti A, Offidani AM, Scalise G.

Mycopathologia. 2001;149(3):117-21.

PMID:
11307593
26.

Interactions between triazoles and amphotericin B against Cryptococcus neoformans.

Barchiesi F, Schimizzi AM, Caselli F, Novelli A, Fallani S, Giannini D, Arzeni D, Di Cesare S, Di Francesco LF, Fortuna M, Giacometti A, Carle F, Mazzei T, Scalise G.

Antimicrob Agents Chemother. 2000 Sep;44(9):2435-41.

27.

Primary resistance to flucytosine among clinical isolates of Candida spp.

Barchiesi F, Arzeni D, Caselli F, Scalise G.

J Antimicrob Chemother. 2000 Mar;45(3):408-9. No abstract available.

PMID:
10702571
28.

In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens.

Barchiesi F, Arzeni D, Fothergill AW, Di Francesco LF, Caselli F, Rinaldi MG, Scalise G.

Antimicrob Agents Chemother. 2000 Jan;44(1):226-9.

29.

In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans.

Barchiesi F, Gallo D, Caselli F, Di Francesco LF, Arzeni D, Giacometti A, Scalise G.

J Antimicrob Chemother. 1999 Jul;44(1):65-70.

PMID:
10459811
30.

Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot.

Scalise A, Barchiesi F, Viviani MA, Arzeni D, Bertani A, Scalise G.

J Infect. 1999 May;38(3):191-2.

PMID:
10424801
31.

Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates.

Barchiesi F, Falconi Di Francesco L, Arzeni D, Caselli F, Gallo D, Scalise G.

Eur J Clin Microbiol Infect Dis. 1999 Mar;18(3):184-7.

PMID:
10357051
32.

In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae.

Barchiesi F, Arzeni D, Compagnucci P, Di Francesco LF, Giacometti A, Scalise G.

Med Mycol. 1998 Dec;36(6):437-40.

PMID:
10206757
33.

In vitro activity of terbinafine against clinical isolates of dermatophytes.

Arzeni D, Barchiesi F, Compagnucci P, Cellini A, Simonetti O, Offidani AM, Scalise G.

Med Mycol. 1998 Aug;36(4):235-7.

PMID:
9776840
34.

Tinea capitis due to Microsporum gypseum in an adult.

Offidani A, Simoncini C, Arzeni D, Cellini A, Amerio P, Scalise G.

Mycoses. 1998 May-Jun;41(5-6):239-41. Review.

PMID:
9715640
35.

Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.

Barchiesi F, Arzeni D, Del Prete MS, Sinicco A, Falconi Di Francesco L, Pasticci MB, Lamura L, Nuzzo MM, Burzacchini F, Coppola S, Chiodo F, Scalise G.

J Antimicrob Chemother. 1998 May;41(5):541-8. Erratum in: J Antimicrob Chemother 1998 Sep;42(3):413.

PMID:
9630407
36.

Comparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients.

Tortorano AM, Viviani MA, Barchiesi F, Arzeni D, Rigoni AL, Cogliati M, Compagnucci P, Scalise G.

J Clin Microbiol. 1998 Jun;36(6):1578-83.

37.

In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.

Barchiesi F, Di Francesco LF, Compagnucci P, Arzeni D, Giacometti A, Scalise G.

J Antimicrob Chemother. 1998 Jan;41(1):59-65.

PMID:
9511038
38.

Genotypic identification of sequential Candida albicans isolates from AIDS patients by polymerase chain reaction techniques.

Barchiesi F, Di Francesco LF, Compagnucci P, Arzeni D, Cirioni O, Scalise G.

Eur J Clin Microbiol Infect Dis. 1997 Aug;16(8):601-5.

PMID:
9323474
39.

Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy.

Arzeni D, Del Poeta M, Simonetti O, Offidani AM, Lamura L, Balducci M, Cester N, Giacometti A, Scalise G.

Eur J Epidemiol. 1997 Jun;13(4):447-50.

PMID:
9258552
40.

Turbidimetric and visual criteria for in vitro susceptibility testing of Cryptococcus neoformans clinical isolates.

Del Poeta M, Barchiesi F, Arzeni D, Marinucci G, Scalise G.

Mycoses. 1994 Nov-Dec;37(11-12):411-6.

PMID:
7659128
41.

Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.

Del Poeta M, Barchiesi F, Morbiducci V, Arzeni D, Marinucci G, Ancarani F, Scalise G.

J Chemother. 1994 Jun;6(3):173-6.

PMID:
7983499
42.

Trichosporon beigelii fungaemia in an AIDS patient.

Barchiesi F, Morbiducci V, Ancarani F, Arzeni D, Scalise G.

AIDS. 1993 Jan;7(1):139-40. No abstract available.

PMID:
8442911
43.

Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.

Barchiesi F, Giacometti A, Arzeni D, Branchesi P, Crescenzi G, Ancarani F, Scalise G.

J Chemother. 1992 Dec;4(6):381-6.

PMID:
1287140
44.

Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.

Arzeni D, Barchiesi F, Ancarani F, Scalise G.

J Chemother. 1991 Jun;3(3):139-42.

PMID:
1655990

Supplemental Content

Loading ...
Support Center